These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3476167)

  • 1. Chronic lymphocytic leukemia and prolymphocytic leukemia: a clinicopathological reappraisal.
    Melo JV; Catovsky D; Galton DA
    Blood Cells; 1987; 12(2):339-53. PubMed ID: 3476167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group.
    Melo JV; Catovsky D; Galton DA
    Br J Haematol; 1986 Jun; 63(2):377-87. PubMed ID: 3487341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features.
    Melo JV; Catovsky D; Gregory WM; Galton DA
    Br J Haematol; 1987 Jan; 65(1):23-9. PubMed ID: 3468997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of 'prolymphocytoid' transformation.
    Melo JV; Catovsky D; Galton DA
    Br J Haematol; 1986 Sep; 64(1):77-86. PubMed ID: 3463362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
    Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
    Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
    Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
    Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL)--a case report].
    Muraoka A; Asami M; Ueno H; Yoneda R; Ogura M; Oribe T; Suzuki K; Maeda M; Chinzei T; Yamashiro K
    Rinsho Ketsueki; 1990 Nov; 31(11):1840-4. PubMed ID: 2287070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic lymphocytic leukemia in Japan].
    Kobayashi T; Kita K; Ohno T; Shirakawa S
    Rinsho Ketsueki; 1990 May; 31(5):554-63. PubMed ID: 2203917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
    Nelson BP; Variakojis D; Peterson LC
    Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-lineage prolymphocytic leukemia as a distinct clinicopathologic entity.
    Katayama I; Aiba M; Pechet L; Sullivan JL; Roberts P; Humphreys RE
    Am J Pathol; 1980 May; 99(2):399-412. PubMed ID: 6929655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
    Schwarze EW
    Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH).
    Bacher U; Kern W; Schoch C; Hiddemann W; Haferlach T
    Ann Hematol; 2004 Jun; 83(6):349-55. PubMed ID: 15034762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. III. Evaluation of cell size by morphology and volume measurements.
    Melo JV; Wardle J; Chetty M; England J; Lewis SM; Galton DA; Catovsky D
    Br J Haematol; 1986 Nov; 64(3):469-78. PubMed ID: 3466642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance.
    Viñolas N; Reverter JC; Urbano-Ispizua A; Montserrat E; Rozman C
    Blood Cells; 1987; 12(2):457-70. PubMed ID: 3620708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
    Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
    Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolymphocytic leukemia.
    Stone RM
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):457-71. PubMed ID: 2182602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolymphocytic transformation of chronic lymphocytic leukemia. A report of three cases and review of the literature.
    Ghani AM; Krause JR; Brody JP
    Cancer; 1986 Jan; 57(1):75-80. PubMed ID: 3455676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay.
    Hicks MJ; Grogan TM; Fielder K; Spier CM
    Diagn Immunol; 1986; 4(1):31-6. PubMed ID: 3456864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.